Get the Full Analysis of the Big 3 Formulary Changes: 2023 Formulary Changes: CVS Health 2023 Formulary Changes: Express Scripts 2023 Formulary Changes: OptumRx As…
Dallas, TX and San Francisco, CA (August 29, 2022) Pharmaceutical Strategies Group (PSG), an EPIC company, announced an enhancement of its data and analytics platform, Artemetrx®,…
Results in PSG’s latest benefit design research reveal an increased focus on member satisfaction DALLAS, Tex. – New research on the latest trends in benefit design launches today. Pharmaceutical…
The Centers for Medicare and Medicaid (CMS) published on May 9, 2022, the highly anticipated Medicare Advantage and Part D Final Rule CMS-4192-F. The intention…
NEW PRODUCT LAUNCH: Pharmaceutical Strategies Group Launches Artemetrx Rebate Monitor Improved oversight of PBM rebates via Artemetrx Rebate Monitor protects the financial interests of health…
Specialty trend increasing at a slower pace but maintains double-digit growth in PSG’s fifth annual integrated pharmacy and medical benefit report DALLAS, Tex. – Pharmaceutical…
The FDA approval of Aduhelm on June 7, 2021, sparked both concern and confusion among stakeholders. There was skepticism that patients in all stages of…